Cargando…

Histone Deacetylase Inhibitors Impair Glioblastoma Cell Motility and Proliferation

SIMPLE SUMMARY: Glioblastoma (GBM) is considered the deadliest brain tumor; with patients displaying a high incidence of relapse and a 3-year survival of only 3–5%. For these reasons, investigation of the molecular basis of the disease could provide novel targets for therapy and improve patient prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rampazzo, Elena, Manfreda, Lorenzo, Bresolin, Silvia, Cani, Alice, Mariotto, Elena, Bortolozzi, Roberta, Della Puppa, Alessandro, Viola, Giampietro, Persano, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027190/ https://www.ncbi.nlm.nih.gov/pubmed/35454804 http://dx.doi.org/10.3390/cancers14081897

Ejemplares similares

Molecular and functional profiling of chemotolerant cells unveils nucleoside metabolism-dependent vulnerabilities in medulloblastoma
por: Mariotto, Elena, et al.
Publicado: (2023)

Collagen VI sustains cell stemness and chemotherapy resistance in glioblastoma
por: Cescon, Matilde, et al.
Publicado: (2023)

HIF-1α/Wnt signaling-dependent control of gene transcription regulates neuronal differentiation of glioblastoma stem cells
por: Boso, Daniele, et al.
Publicado: (2019)

Effects of Ultra-Short Pulsed Electric Field Exposure on Glioblastoma Cells
por: Casciati, Arianna, et al.
Publicado: (2022)

Annexin 2A sustains glioblastoma cell dissemination and proliferation
por: Maule, Francesca, et al.
Publicado: (2016)

AKR1C enzymes sustain therapy resistance in paediatric T-ALL
por: Bortolozzi, Roberta, et al.
Publicado: (2018)

The Three-Layer Concentric Model of Glioblastoma: Cancer Stem Cells, Microenvironmental Regulation, and Therapeutic Implications
por: Persano, Luca, et al.
Publicado: (2011)

Wnt Signaling in Brain Tumors: A Challenging Therapeutic Target
por: Manfreda, Lorenzo, et al.
Publicado: (2023)

Wnt activation promotes neuronal differentiation of Glioblastoma
por: Rampazzo, E, et al.
Publicado: (2013)

Wnt activation promotes neuronal differentiation of Glioblastoma
por: Rampazzo, E, et al.
Publicado: (2013)

Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities
por: Romagnoli, Romeo, et al.
Publicado: (2022)

Choline Kinase Alpha Inhibition by EB-3D Triggers Cellular Senescence, Reduces Tumor Growth and Metastatic Dissemination in Breast Cancer
por: Mariotto, Elena, et al.
Publicado: (2018)

The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation
por: Porcù, Elena, et al.
Publicado: (2016)

The application of histone deacetylases inhibitors in glioblastoma
por: Chen, Rui, et al.
Publicado: (2020)

BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression
por: Persano, L, et al.
Publicado: (2012)

Histone deacetylase enzymes and selective histone deacetylase inhibitors for antitumor effects and enhancement of antitumor immunity in glioblastoma
por: Yelton, Caleb J., et al.
Publicado: (2018)

Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold
por: Romagnoli, Romeo, et al.
Publicado: (2023)

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016)

Ecdysteroid Derivatives that Reverse P-Glycoprotein-Mediated Drug Resistance
por: Bortolozzi, Roberta, et al.
Publicado: (2020)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Histone Deacetylase Inhibitors Impair Vasculogenic Mimicry from Glioblastoma Cells
por: Pastorino, Olga, et al.
Publicado: (2019)

Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
por: Meng, Wei, et al.
Publicado: (2018)

Long-term proliferation of immature hypoxia-dependent JMML cells supported by a 3D in vitro system
por: Cani, Alice, et al.
Publicado: (2022)

Effects of valproic acid on histone deacetylase inhibition in vitro and in glioblastoma patient samples
por: Berendsen, Sharon, et al.
Publicado: (2019)

Remarkable response of a patient with secondary glioblastoma to a histone deacetylase inhibitor
por: Gurbani, Saumya S, et al.
Publicado: (2020)

Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model
por: Pająk, Beata, et al.
Publicado: (2021)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents
por: Oliva, Paola, et al.
Publicado: (2022)

A novel copper(I) complex induces ER-stress-mediated apoptosis and sensitizes B-acute lymphoblastic leukemia cells to chemotherapeutic agents
por: Bortolozzi, Roberta, et al.
Publicado: (2014)

Molecular Mechanisms of HIF-1α Modulation Induced by Oxygen Tension and BMP2 in Glioblastoma Derived Cells
por: Pistollato, Francesca, et al.
Publicado: (2009)

Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
por: Ceccacci, Elena, et al.
Publicado: (2016)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Microfluidic Lab-on-a-Chip Based on UHF-Dielectrophoresis for Stemness Phenotype Characterization and Discrimination among Glioblastoma Cells
por: Lambert, Elisa, et al.
Publicado: (2021)

Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells
por: Li, Dengwen, et al.
Publicado: (2014)

Histone deacetylase inhibition leads to regulatory histone mark alterations and impairs meiosis in oocytes
por: Legoff, Louis, et al.
Publicado: (2021)

Chemical Phylogenetics of Histone Deacetylases
por: Bradner, James E., et al.
Publicado: (2010)

Histone deacetylases in viral infections
por: Herbein, Georges, et al.
Publicado: (2010)

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

Histone deacetylase signaling in cardioprotection
por: Lehmann, Lorenz H., et al.
Publicado: (2013)

Histone deacetylase 6 in cancer
por: Li, Ting, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sdqd2qr9qp048cfedkto7gvdsu